1. Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease. (April 2021) Authors: Frank, Samuel; Vaughan, Christina; Stamler, David; Oakes, David; Davis, Mat D.; Gross, Nicholas; Gordon, Mark Forrest; Savola, Juha-Matti; Wieman, Maria; Eberly, Shirley; Kayson, Elise; Whaley, Jacquelyn; Goldstein, Jody; Testa, Claudia M. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-label Study. (April 2021) Authors: Frank, Samuel; Testa, Claudia M.; Stamler, David; Kayson, Elise; Oakes, David; Vaughan, Christina; Goldstein, Jody; Whaley, Jacquelyn; Davis, Mat D.; Gordon, Mark Forrest; Savola, Juha-Matti Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗